Inventor · disambiguated record
Grant E. Blouse
Also filed as: BLOUSE GRANT E · BLOUSE GRANT ELLSWORTH
5 granted patents·9 pending applications·29 citations·filing 2011–2024
75Inventor score
Top patents by PatentIndex Score
14 records- 0193US8778870B2Modified factor IX polypeptides and uses thereofMADISON EDWIN L·Filed 2011·Granted Jul 15, 2014·24 cites·37 claims
- 0282US11266724B2Modified factor VII polypeptides for subcutaneous administration and on-demand treatmentCATALYST BIOSCIENCES INC·Filed 2021·Granted Mar 8, 2022·1 cites·17 claims
- 0381US9328339B2Modified factor IX polypeptides and uses thereofMADISON EDWIN L·Filed 2014·Granted May 3, 2016·4 cites·30 claims
- 0470US2021230570A1Modified factor ix polypeptides and uses thereofCATALYST BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 0566US2025136965A1Complement factor i-related compositions and methodsVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 0665US2024117334A1Factor b proteasesVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 0762US10982203B2Modified factor IX polypeptides and uses thereofCATALYST BIOSCIENCES INC·Filed 2016·Granted Apr 20, 2021·0 cites·42 claims
- 0862US2025177482A1Complement factor i dosing regimens for treating ocular diseasesVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 0959US12116606B2Complement factor I-related compositions and methodsVERTEX PHARMA·Filed 2021·Granted Oct 15, 2024·0 cites·20 claims
- 1057US2021069306A1Modified factor vii polypeptides for subcutaneous administration and on-demand treatmentCATALYST BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1154US2025011379A1Complement factor i-related compositions and methodsVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1252US2025277200A1Engineered cpn1 constructs and variantsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 1349US2021238260A1Gene therapy for hemophilia b with a chimeric aav capsid vector encoding modified factor ix polypeptidesCATALYST BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1439US2016024487A1Thrombin sensitive coagulation factor x moleculesNOVO NORDISK AS·Filed 2014·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →